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LABORATORY INVESTIGATION
Endothelin- 1 activates c-Jun NH2-terminal kinase in
mesangial cells
SHIN-IcHI Aii, MASAKAZU HANEDA, MASAKI TOGAWA, and RYuIcHI KIKKAWA
The Third Department of Medicine, Shiga University of Medical Science, Shiga, Japan
Endothelin-1 activates c-Jun Nt12-terminal kinase in mesangial cells.
Endothelin-l (ET-1) is known to induce the contraction and proliferation
of glomerular mesangial cells. ET-1 has been shown to activate p42 and
p44 mitogen-activated protein kinases (MAPKs), also known as extracel-
lular signal regulated kinases (ERKs), through both protein kinase C
(PKC) and protein tyrosine kinase (PTK)-dependent pathways. However,
an involvement of c-Jun NH2-terminal kinase (JNK), one of members of
the MAPK family, in ET-1 signaling in mesangial cells has not yet been
elucidated. To clarify this point, we examined whether ET-1 could activate
JNK and the mechanism of activation in cultured mesangial cells. ET-1
enhanced the activities of JNK in a dose-dependent (10—8 M maximum)
and time-dependent manner, with a peak at .15 minutes. ET-1-induced
activation of JNK was blocked by BQ-123, an antagonist for the ETA
receptor. The depletion of PKC by prolonged treatment with phorbol
12,13 dibutyrate or the inhibition of PKC by GF 109203X failed to inhibit
ET-1-induced activation of JNK. In contrast, ET-1-induced activation of
JNK was significantly reduced by calcium chelation (with BAPTAJAM and
EGTA). In addition, ionomycin, a calcium ionophore, and thapsigargin,
an intracellular calcium-rising agent, were able to induce the activation of
JNK. ET-1-induced activation of JNK was also inhibited by PTK inhibitors
(herbimycin A and genistein). Furthermore, ET-1 increased the DNA-
binding activity of AP-1 containing c-Jun and c-Fos proteins. These results
indicate that ET-1 is able to activate JNK in glomerular mesangial cells
through PKC-independent and PTK-dependent pathways and intracellu-
lar calcium is necessary to the activation of iNK.
Glomerular mesangial cells have receptors specific to various
vasoconstrictive substances such as endothelin [1], angiotensin II
[2] and vasopressin [3], and to vasodilating substances such as
atrial natriuretic peptide [4]. These substances are considered to
cause the contraction or relaxation of mesangial cells, to induce
changes in the glomerular capillary surface are-a available for
ultrafiltration and thus to regulate glomerular filtration rate [5, 6].
Endothelin-1 (ET-i), one of the most potent vasoconstrictors, is
known to not only induce the contraction hut to act as a mitogen
in cultured mesangial cells [7]. In order to understand the
mesangial action of ET-1, it is important to clarify the signal
transduction system of ET-1 in mesangial cells. ET-1 binds to (1
protein-coupled receptors with seven transmemhrane domains
and activates phospholipase C13 (PLCI3), resulting in a production
of inositol 1,4,5-trisphosphate and diacyiglycerol, which increases
cytosolic Ca2 and activates protein kinase C (PKC), respectively
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[5, 7, 81. In addition, non-receptor protein tyrosine kinases (PTK5)
such as Src [8] and focal adhesion kinase [9] were also shown to be
involved in the signal transduction pathway of ET-1. We and
others have shown that ET-l is able to activate p42 and p44
mitogen-activated protein kinases (MAPKs), also known as extra-
cellular signal regulated kinases (ERKs) [10—12], important ki-
nases in the transduction of various extracellular signals to cellular
responses [13, 14]. ET-1-induced activation of ERK was shown to
be mediated by PKC- and PTK-dependent pathways [10].
Recently, one of members of the MAPK family, c-Jun NH2-
terminal kinase (JNK), also known as stress-activated protein
kinase (SAPK), has been identified in yeast and mammalian cells
[15, 16]. JNK was shown to bind to a specific region within a
transactivation domain of c-Jun and to phosphorylate serine
residues 63 and 73 of c-Jun [17]. In addition to the phosphoryla-
tion of c-fun, JNK was also found to cause the phosphorylation of
transcription factors, ATF2 and Elk-i, and to increase their
transcriptional activating potential [15, 16, 18, 19]. These findings
indicate that iNK may play an important role in various cellular
functions. JNK was found to be activated in response to UV
irradiation, heat shock, changes in extracellular osmolarity, and
cytokines such as tumor necrosis factor a (TNFa) and IL-i in
various types of cells [15, 16, 20—22]. Recently, angiotensin II and
carbachol, agonists for G protein-coupled receptors with seven
transmembrane domains, have been reported to induce the
activation of JNK in GN4 rat liver epithelial cells [231 and in NIH
3T3 cells in which Gq-coupled muscarinic acetylcholine receptors
were overexpressed [24], respectively. From these findings, we
hypothesized that JNK could be involved in the signal transduc-
tion system of ET-i in glomerular mesangial cells. The present
study was thus performed to determine whether ET-1 could
induce the activation of JNK and to clarify the mechanisms
involved in the activation of iNK.
Methods
Materials
Rat ET-1 was obtained from Peptide Institute (Suita, Japan).
The glutathione-S-transferase (GST) fusion protein expression
vector containing the transactivation domain of c-Jun (amino
acids 1-79), pGEX2T-c-Jun, was a gift of Dr. Michael Karin
(University of California, San Diego, CA, USA). Anti-JNK1 (FL),
anti-c-Jun and anti-c-Fos antibodies were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Consensus oligonu-
cleotides of AP-1 and NF-KB was purchased from Promega
(Madison, WI, USA). Glutathione Sepharose 4B and protein G
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Fig. 1. Expression of iNK proteins and the activation of JNK by ET-/ in cultured mesangial cells. Cell lysates from cultured mesangial cells were subjected
to SDS-PAGE (10%) followed by immunoblot analysis with anti-JNKI antibody that could recognize both 46 kDa and 55 kDa JNK (A). Cell lysates
from cells exposed to 10_8 M ET-1 for the indicated time intervals were immunoprecipitated with anti-JNK1 antibody and the activities of JNK were
determined by the immune complex kinase assay (B), or cell lysates were incubated with GST-c-Jun bound to glutathione sepharose beads and kinase
reactions were performed on the beads (C, the solid-phase kinase assay). The position of the GST-c-Jun band is indicated by the arrowhead. The proteins
bound to GST-c-Jun were subjected to the in-gel kinase assay with GST-c-Jun as a substrate (D, C, control; E, stimulated with iO- M ET-1 for 15 mm).
Sepharose were purchased from Pharmacia Biotechnology (Upp-
sala, Sweden). BQ-123 was a gift of Banyu Pharmaceutical Co.,
Ltd. (Tsukuba, Japan). Genistein, herbimycin A, phorbol 12,13-
dibutyrate (PDBu) were purchased from Sigma (St. Louis, MO,
USA). lonomycin and thapsigargin were obtained from Calbio-
chem (La Jolla, CA, USA). GF 109203X and 1,2-bis-(o-amino-
phenoxy)-ethane-N,N,N',N'-tetraacetic acid tetraacetoxymethyl-
ester (BAPTAJAM) were purchased from Wako Pure Chemical
Industries, Ltd. (Osaka, Japan). [y-32PJATP (6000 Ci/mmol) was
bought from New England Nuclear Research Products (Boston,
MA, USA). All other reagents were chemical grade and pur-
chased from standard suppliers.
Mesangial cell culture and experimental protocol
Glomerular mesangial cells were obtained from a culture of
glomeruli which was isolated from male Sprague-Dawley rats
weighing 100 to 150 g by a sieving method as previously described
[25]. Isolated glomeruli were cultured in RPMI 1640 medium
containing 20% heat-inactivated fetal bovine serum (FBS), 100
U/mi penicillin, 100 xg/m1 streptomycin, 5 xg/ml insulin, 5 j.tg/ml
transferrin and 5 ng/ml selenious acid. Cultured cells were iden-
tified as mesangial cells by morphological and biochemical char-
acters as previously described [25, 261. Cells at passages between
2 and 9 were used for the following experiments.
Subconfluent (80%) mesangial cells were made quiescent by
reducing the concentrations of FBS to 0.4% for 48 hours. Quies-
cent mesangial cells were incubated in an incubation medium
(RPMI 1640 medium with 0.4% fatty acid free bovine serum
albumin and 20 mM 1-lepes, pH 7.4) at 37°C for 30 minutes. Cells
were then incubated with various concentrations of ET-l at 37°C
for indicated time intervals. The reactions were terminated by a
rapid aspiration of medium and washing twice with ice-cold
phosphate buffered saline (PBS) on ice. The cells were lysed in a
buffer containing 25 mi Hepes, pH 7.5, 0.3 M NaCI, 1.5 mM
MgCl2, 0.2 m'vi EDTA, 0.5 mrvi dithiothreitol (DTT), 20 mM
f3-glycerophosphate, 1 ifiM vanadate, 0.1% Triton X-100, 1 m
phenylmethylsulfonyl fluoride (PMSF), 20 jxg/ml aprotinin, and
20 xg/ml leupeptin. The cell lysates were centrifuged at 12,000 g
for 30 minutes and the supernatants were used for JNK assay. The
concentrations of cellular protein were determined using Bio-Rad
protein assay kit.
Preparation of GST-c-Jun
The GST fusion protein expression vector, pGEX2T-c-Jun, was
transformed into E. coli. The bacterial iysates containing the
fusion protein were incubated with giutathione Sepharose 4B and
GST-c-Jun (1-79) fusion protein bound to glutathione sepharose
beads was collected by centrifugation. The purity and amounts of
purified proteins were estimated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and subsequent
staining with Coomasse blue. For a substrate of the in-gel kinase
assay, GST-c-Jun (1-79) bound to glutathione Sepharose 4B was
cluted using 5 mM glutathione.
Measurement of the activities of JNK
The activities of JNK were measured by the solid-phase kinase
assay [271, the immune complex kinase assay [21] or the in-gel
kinase assay [27]. For the solid-phase kinase assay, cell lysates
were incubated with GST-c-Jun (1-79) fusion protein bound to
glutathione-sepharose beads at 4°C for three hours. The beads
were recovered by centrifugation at 10,000 g for 10 seconds and
then washed three times with a buffer containing 20 mat Hepes,
pH 7.7, 50 mivi NaCl, 2.5 mist MgC12, 0.1 mist EDTA and 0.05%
Triton X-100, and once with a kinase buffer (20 mM Hepes, pH
7.6, 20 mist MgC12, 20 mat /3-glycerophosphate, 20 misi p-nitrophe-
nyl phosphate, 0.1 mist vanadate, 2 mat DTf). The beads were
then incubated with 30 pA of a kinase buffer containing 20 1ILM
unlabeled ATP and 5 1xCi [y-32P]ATP at 30°C for 20 minutes. The
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Fig. 2. Dose-dependent effect of ET-1 on the activities of JNK Cells were
exposed to various concentrations of ET-l for 15 minutes and the activities
of JNK were measured by the solid-phase kinase assay. A representative
autoradiograph (A) and the relative kinase activities of JNK (B) are
shown. Values are mean so (N = 3). *P < 0.05, **p < 0.01 versus basal
(without ET-1).
reaction was terminated by the addition of 30 j.tl of 3 X Laemmli
sample buffer and boiling at 100°C for five minutes. Phosphory-
lated proteins were resolved on 12% SDS-PAGE, followed by an
autoradiography. The relative kinase activities were quantified by
the densitometric analysis of autoradiographs.
For the immune complex kinase assay, cell lysates were immu-
noprecipitated with anti-JNK1 polyclonal antibody at 4°C for four
hours. Immunoprecipitates were recovered with the aid of protein
G Sepharose, and the ability of immunoprecipitates to phosphor-
ylate GST-c-Jun was evaluated by incubation with purified OST-
c-Jun (1-79) in 30 jil of a kinase buffer containing 20 J.CM unlabeled
ATP and 5 jiCi [y-32PIATP, as described above.
For the in-gel kinase assay, cell lysates were incubated with
GST-c-Jun (1-79) and the proteins bound to (iST-cjun (1-79)
were eluted with Laemmli sample buffer. The eluted proteins
were resolved on 10% SDS-PAGE containing 0.1 mg/mi GST-c-
Jun (1-79). After electrophoresis, the gel was washed twice for 30
minutes with 20% 2-propanol in buffer A (50 mivt Hepes, pH 7.4,
5 mM mercaptoethanol) to remove SDS. The gel was then washed
twice for 30 minutes with buffer A and incubated at room
temperature for one hour with 6 M guanidine-HCI in buffer A to
denature the proteins. To renature the proteins, the gel was
incubated with 0.04% Tween 40 in buffer A at 4°C for 16 hours.
The kinase reaction was carried out at 30°C for one hour in the
kinase buffer containing 10 j.LM ATP and 250 jsCi [y-32P]ATP.
Finally, the gel was extensively washed with 5% trichloroacetic
acid and 10 m sodium pyrophosphate, followed by drying and
autoradiography.
Immunoblot analysis of JNK
The supernatants of cell lysates containing 75 jig protein were
subjected to 10% SDS-polyacrylamide gels and transferred onto
irnmobilon P membranes (Millipore, Marbolo, MA, USA). The
membranes were probed with anti-JNK-1 antibody (diluted at
1:500). A horseradish peroxidase-conjugated secondary antibody
(1:2000) was used to allow the detection of immunoreactive bands
using the enhanced chemiluminescence detection system (Amer-
sham, Buckinghamshire, UK).
Assessment of DNA -binding activity of AP-i
Nuclear extracts were prepared as described by Sadowski and
Gilman with modifications [28]. In brief, cells were lysed by the
addition of hypotonic buffer (20 mrvt Hepes, pH 7.9, 1 mi EGTA,
1 mM EDTA, 20 ms'i NaF, 1 mi Na3VO4, 1 ms Na4P2O7, 1 mM
DIT, 0.5 ms PMSF, I jig/mI aprotinin, 1 j.tg/ml leupeptin and 1
jig/mI pepstatin) with 0.6% Nonidet P-40 and lysates were cen-
trifuged at 16,000 g for 20 seconds. The pellets were resuspended
in high salt buffer (hypotonic buffer with 420 mivi NaCI and 20%
glycerol), rotated for 30 minutes at 4°C and centrifuged at 16,000
g for 20 minutes. The supernatants were used as nuclear proteins
for a gel mobility shift assay. The nuclear proteins (3 jig) were
incubated with 2 jig of poly(dI-dC)apoly(dI-dC) in a binding
buffer (20 mrvi Hepes, pH 7.9, 1.8 mjvi MgCI2, 2 mM DTT, 0.5 mM
EDTA, 0.5 mg/mI BSA) for 30 minutes and then reacted with a
radiolabeled AP-i consensus oligonucleotide at room tempera-
ture for 20 minutes. The reactin mixtures were electrophoresed
through 6% polyacrylamide gel and autoradiographed. The com-
petition experiments were performed using unlabeled AP-1 or
NF-KB oligonucleotides. Supershift assays were performed by the
addition of antibodies against c-Jun or c-Fos.
Statistical analysis
Results were expressed as mean SD. Analysis of variance
(ANOVA) with subsequent Scheffé's test was used to determine
significant difference in multiple comparisons.
Results
ET-1 -induced activation of JNK in mesangial cells
iNK in cultured glomerular mesangial cells was identified by
immunoblot analysis using anti-JNKI antibody that could recog-
nize both 46 kDa JNK and 55 kDa JNKs. As shown in Figure IA,
the expression of both 46 kDa and 55 kDa iNK proteins were
detected in mesangial cells. We next examined whether ET-1
could activate iNK. In the immune complex kinase assay with
anti-JNK1 antibody, ET-1 (10 M) enhanced the activities of
iNK in a time-dependent manner with a maximal stimulation at
15 minutes (Fig, 1B) and the activities of JNK returned to the
basal levels after 60 minutes. The activities of JNK were also
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Fig. 3. Effect of BQ-123, an ETA receptor antagonist, on ET-1 -induced activation of JNK Cells were treated with various concentrations of BQ-123 for
10 minutes, exposed to iO MET-I for additional 15 minutes, and the activities of JNK were measured by the solid-phase kinase assay. A representative
autoradiograph from three different experiments is shown.
determined using the solid-phase kinase assay. Since purified
GST-c-Jun (1-79) contains the JNK binding domain and JNK-
induced phosphorylation regions (Ser 63 and 73), we are able to
use GST-c-Jun (1-79) both for the isolation of JNK by its binding
and as a substrate for JNK on the solid-phase kinase assay [27]. As
shown in Figure 1C, ET-1 enhanced the activities of JNK in the
solid-phase assay in the same time-dependent manner as in the
immune complex kinase assay. To confirm whether the kinases
bound to GST-c-Jun (1-79) in the solid-phase kinase assay were
JNK, we performed the in-gel kinase assay. As shown iii Figure
ID, the molecular mass of kinases bound to GST-c-Jun were 46
kDa and 55 kDa, and both kinases were activated by ET-1.
Furthermore, no other band was detected by the in-gel kinase
assay. ET-l-induced activation of JNK was also observed in a
concentration-dependent manner with a maximal stimulation at
10 -8 M ET-1 in the solid-phase kinase assay (Fig. 2). Therefore, in
subsequent experiments, we used the solid-phase kinase assay for
the determination of the activities of JNK and cells were stimu-
lated with 108 M ET-1 for 15 minutes.
Mechanism of ET-i -induced activation of JNK in mesangial cells
To know the subtype of ET-1 receptors responsible for ET-1-
induced activation of iNK, the effect of BQ-123, an antagonist for
ETA receptor, was examined. As shown in Figure 3, ET-1 -induced
activation of JNK was inhibited by treating the cells with BQ-123
for 10 minutes prior to the stimulation with ET-1. The inhibition
was observed in a concentration-dependent manner of BQ-123
and ET-1-induced activation of JNK was almost completely
inhibited by 10 6 to i0 M of BQ-123.
Because the binding of ET-1 to ETA receptor was found to
activate PLCp, resulting in an activation of PKC and an increase
in intracellular Ca24 [7, 291, we next examined which pathway
would be responsible for ET-1-induced activation of JNK, First,
we examined the contribution of PKC-dependent pathway by
treating the cells with i0 M PDBu for 16 hours to deplete PKC
[9] or with 2Xi0' M GF 109203X [30], a PKC specific inhibitor,
for 15 minutes prior to the stimulation with ET-1. As shown in
Figure 4, neither the depletion nor the inhibition of PKC could
affect ET-l-induced activation of JNK. We next examined the
contribution of intracellular Ca2 to ET-1-induced activation of
JNK. In order to chelate intracellular Ca2, the cells were treated
with 50 !.LM BAPTA/AM, a membrane-permeable calcium chela-
tor, for 30 minutes and then with 2 ma EGTA for last two minutes
in a calcium-free medium (140 mi NaC1, 5 ms'i KC1, 1 mM
MgSO4, 10 m glucose, 10 mrvi Hepes, pH 7.4) prior to the
ET-1, M 0 10-8 0 10-8 0 108
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Fig. 4. Effects of a depletion and an inhibition of PKC on ET-1 -induced
activation of JNK. Cells were treated with iO— PDBu for 16 hours or
2X10 M GF 109203X for 15 minutes, exposed to t08 M ET-1 for
additional IS minutes, and the activities of JNK were measured by the
solid-phase kinasc assay. A representative autoradiograph (A) and the
relative kinase activities of JNK (B) are shown. Values are mean SD
(N = 5). p < 0.05, **P < 0.01 versus basal.
stimulation with ET-1. The chelation of intracellular Ca2 re-
sulted in a significant reduction of ET-l-induced activation of
iNK (Fig. 5). The effect of the omission of intracellular Ca2 was
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Fig. 5. Effect of the chelation of calcium with
BAPTA/AM and EGTA on ET-] -induced
activation of JNK Cells were treated with 50
ILM BAPTA/AM for 30 minutes, followed by 2
mM EGTA for last two minutes, exposed to
iO M ET-1 for additional 15 minutes, and the
activities of JNK were measured by the solid-
phase kinase assay. In lane 5, after the
chelation of calcium, cells were washed,
resupplemented with 2 mrvt CaCl2, exposed to
iO M ET-1 for additional 15 minutes and the
activities of JNK were measured. A
representative autoradiograph (A) and the
relative kinase activities of JNK (B) are shown.
Values are mean SD (N = 3). *P < 0.01
versus basal, BAPTAJAM and BAPTA!
AM+ET-1.
reversible because ET-1 was able to enhance JNK activities in the
cells resupplemented with 2 ms CaC12, suggesting the involve-
ment of intracellular Ca2 in ET-1-induced activation of JNK. To
further clarify the role of calcium in the activation of JNK, we
examined the effects of two different intracellular calcium-increas-
ing agents: ionomycin, a calcium ionophore, and thapsigargin, an
agent that prevents reuptake of intracellular calcium into storage
vesicles, on the activities of JNK in mcsangial cells. Both agents
increased the activities of JNK in a time-dependent manner,
although the maximal effect was slightly delayed as compared with
that by El-I (Fig. 6).
Recently, the protein tyrosine kinase (PTK) pathway has been
reported to be involved in the action of Er-i in mesangial cells
[8]. Therefore, we examined the effects of two specific PTK
inhibitors, herbimycin A and genistein, on ET-1-induced activa-
tion of JNK. Both compounds were shown to be chemically
different and to have different modes of action [31, 32]. Treating
the cells with either PTK inhibitor prior to the stimulation with
El-I resulted in a concentration-dependent inhibition of ET-1-
induced activation of JNK (Fig. 7), while basal activities of JNK
were not affected by either 1 .LM herbimycin A or 300 .rM genistein
(data not shown).
ET-1-induced activation of AP-1 DNA binding
Since c-Jun was one of the transcriptional factors forming the
AP-1 complex and the phosphorylation of c-Jun was found to
enhance the DNA-binding activity of AP-1 [33], we examined
whether ET-1 could activate AP-1 DNA binding in mesangial
cells. As shown in Figure 8A, ET-1 was able to increase the
DNA-binding activity of AP-1 from 30 minutes with a peak
activation at 60 minutes. The incubation with a excess of an
unlabeled AP-i consensus sequence in the binding reaction
resulted in competition for protein binding to the radiolabcled
AP-1 probe but not with unlabeled NF-xB, Furthermore, the
addition of antibodies against c-Jun or c-Fos to the binding
reaction resulted in a shift of the binding complex to a slow
migrating species (Fig. 8B). These results suggested that both
c-Jun and c-Fos proteins were involved in the formation of the
DNA-binding complex of AP-1 in cells stimulated by ET-1 for one
hour.
Discussion
The present study indicates that ET-1 is able to induce the
activation of JNK, one of members of the MAPK family, through
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ETA receptor in cultured glomerular mesangial cells. The data
also indicate that ETA -induced activation of JNK is mediated by
PKC-independent and PTK-dependent pathways and intracellular
calcium is necessary to its activation. Since ERK was shown to be
activated by ET-1 through PKC- and PTK-dependent pathways
[101, the present results could raise the possibility that the signal
transduction systems of ET-1 involved in the activation of JNK
and ERK are different in mesangial cells.
Since glomerular mesangial cells are one of the major target
cells of ET-1 and ET-1 is known to induce the contraction,
proliferation, and production of extracellular matrix in mesangial
cells [34], it is important to elucidate the signal transduction
pathways of ET-1 to clarify the mechanism of the action of ET-1
in mesangial cells. Recent studies have indicated that the MAPK
family plays an important role in the signaling pathways in
response to diverse extraeellular stimuli [13, 14]. The MAPK
family consists of at least three subfamilies: ERK (also known as
p44 MAPK and p42 MAPK), JNK (also known as SAPK) and p38
kinase [35]. We and others have reported that ET-1 could activate
p42 and p44 MAPKs (ERK5) in mesangial cells [10—12, 36]. The
present study clearly indicates that ET-1 is also able to activate
JNK in mesangial cells. In contrast to ERK, JNK has been
reported to be strongly activated by stress-inducing stimuli, in-
cluding UV irradiation, heat shock and cytokines in various types
of cells [15, 16, 20—22]. However, in mesangial cells, ET-i seems
to activate JNK to the similar degree as ERK [10, 36]. Therefore,
both ERK and iNK could be considered to participate in the
signal transduction system of FT-i in mesangial cells.
Although both ERK and JNK are activated by FT-I through
ETA receptors in mesangial cells, the pathways distal to ETA
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receptors seem to be different. First, the time course of FT-i-
induced activation of JNK (maximal stimulation at 15 mm) was
slightly different from that of FT-i-induced activation of ERK
(maximal stimulation between 5 and 10 mm) [10, 36]. The slower
response of JNK than ERK has been also reported in MRC-5
human fibroblast cells stimulated with TNFa, in GN4 rat liver
epithelial cells with angiotensin II, and in NIH 3T3 cells with
carbachol [21, 23, 24, 37]. Secondly, in the present study, neither
the depletion of PKC by prolonged treatment of PDBu nor the
inhibition of PKC by OF 109203X was able to inhibit FT-I -
induced activation of JNK, indicating that PKC-independent
pathway might be involved in FT-i -induced activation of JNK. On
the other hand, ERK was found to be activated by FT-i through
a PKC-dependent pathway in mesangial cells [10]. Finally, the
chelation of intracellular calcium by treating the cells with
BAPTAI'AM and EGTA resulted in a significant reduction of
FT-i-induced activation of JNK and two different intracellular
calcium-increasing agents, ionomycin and thapsigargin, were able
to enhance the activities of JNK in mesangial cells, although the
peak activation of JNK by calcium increasing agents was slightly
delayed as compared with that by ET-i. On the contrary, iono-
mycin was recently shown not to activate ERK in mesangial cells
[38]. Therefore, in contrast to ERK, FT-I -induced activation of
JNK is considered to be mediated by a PKC-independent pathway
and intracellular calcium is necessary to the activation of JNK in
mesangial cells.
In the present study, we also found that two different tyrosine
kinase inhibitors (herbimycin A and genistein) were able to inhibit
FT-i-induced activation of JNK. ET-1 was shown to enhance
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tyrosine phosphorylation of several proteins by a PKC-indepen-
dent pathway [391 and the activation of PTK was found to be
required for the induction of immediate early response genes by
ET-1 in mesangial cells [8]. Therefore, the regulation of transcrip-
tion factors by ET-1 might be at least partially mediated through
the PTK-dependent activation of JNK, and this pathway might be
mediated by Ca2-dependent tyrosine phosphorylation, as sug-
gested in rat liver epithelial cells stimulated with angiotensin II
[231.
JNK has been reported to phosphosylate several transcription
factors (c-Jun, ATF2 and Elk-i) that contribute to the stimulation
of AP-1 activity [15, 16, 18, 19], and Elk-i was also shown to be a
substrate for ERK [401. In the present study, we demonstrated
that ET-1 rapidly increased the DNA-binding activity of AP-1
containing c-Jun and c-Fos proteins. Therefore, ET-1 may en-
hance the DNA-binding activity of AP-i by activating both JNK
and ERK and thus control the expression of a number of genes.
On the other hand, JNK has been recently reported to induce the
expression of a mitogen-activated protein kinase phosphatase
(MKP-1) [411, which is capable of inactivating ERK in mesangial
cells [42]. In addition, it has been also reported that the activation
of JNK might contribute to apoptosis of PC-12 cells, opposing the
effect of ERK [43]. Therefore, the cooperation and cross-talk
between ERK and iNK might regulate the cellular responses
induced by ET-1. Although these functions of iNK and the
expression of multiple JNK isoforms [I need to be further
clarified in mesangial cells, the present study indicates that JNK
may serve as one of the important signals induced by ET-1 in
glomerular mesangial cells.
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